<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="55969">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02377518</url>
  </required_header>
  <id_info>
    <org_study_id>5601</org_study_id>
    <nct_id>NCT02377518</nct_id>
  </id_info>
  <brief_title>DECT Ventilation Imaging</brief_title>
  <official_title>Quantitative Ventilation Imaging With Dual Energy Computed Tomography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Demonstrate the feasibility of dual energy computed tomography using Krypton as a gaseous
      contrast media in order to study the in vivo ventilation.

      Two different clinical situations will be tested :

        -  Prediction of postoperative pulmonary function for oncologic patients

        -  Detection of Bronchiolitis Obliterans in lung transplant recipients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Image quality on a qualitative 5 levels scale</measure>
    <time_frame>1 day of DECT ventilation imaging</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radiation dose</measure>
    <time_frame>1 day of DECT ventilation imaging</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Image noise with measurement of signal to noise and contrast to noise ratios</measure>
    <time_frame>1 day of DECT ventilation imaging</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total examination time</measure>
    <time_frame>1 day of DECT ventilation imaging</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>For Oncologic Patients</condition>
  <condition>Potentially Operable Lung Tumor</condition>
  <condition>With a Recent (Less Than 1 Month) VQ Scan</condition>
  <condition>For Lung Transplant Recipients</condition>
  <condition>Single of Bilateral Lung Transplant</condition>
  <condition>From 5 Months Onwards</condition>
  <condition>With Recent (Less Than 1 Month) Respiratory Functional Explorations</condition>
  <arm_group>
    <arm_group_label>oncologic patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prediction of postoperative pulmonary function.
Patients with an operable lung cancer: dual energy computed tomography with Krypton will be tested to estimate the postoperative FEV1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lung transplant recipients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Detection of BOS
6 months+ lung transplant recipients will be tested using dual energy computed tomography with Krypton, with acquisition in the end-inspiratory and end-expiratory phase, in search of regional air trapping.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Single source dual energy compted tomography (CT750HD, General Electric, USA) with Krypton as a gaseous contrast media</intervention_name>
    <arm_group_label>oncologic patients</arm_group_label>
    <arm_group_label>lung transplant recipients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

        For oncologic patients :

          -  Potentially operable lung tumor

          -  With a recent (less than 1 month) V/Q scan

        For lung transplant recipients :

          -  Single of bilateral lung transplant

          -  From 5 months onwards

          -  With recent (less than 1 month) respiratory functional explorations

        Exclusion criteria:

          -  Impossibility to follow simple orders or control one's respiration

          -  Known Krypton hypersensitivity

          -  History of malignant hyperthermia

          -  Increased intracranial pressure

          -  Minors

          -  Pregnant Women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mickaël OHANA, MD</last_name>
    <email>mickael.ohana@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service de Radiologie B - Nouvel Hôpital Civil - CHRU de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091 Cedex</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mickaël OHANA, MD</last_name>
      <phone>369551117</phone>
      <phone_ext>0033</phone_ext>
      <email>mickael.ohana@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Mickaël OHANA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Catherine ROY, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mi-Young JEUNG, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <lastchanged_date>April 4, 2017</lastchanged_date>
  <firstreceived_date>February 25, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
